✨ AB Cube’s 2026 roadmap ✨
Smarter, faster, global pharmacovigilance.
🚀 CasEasy V3
⚡ Converter V2
🌍 Multizone: Korea Japan
🔗 New APIs (E2B)
🤝 Reconciliation upgrades
➕ Signal Mgmt & RWE
We’re not keeping pace — we’re setting it. 🏃♀️
#pharmacovigilance
9 in 10 medicines fail during development – often due to challenges predicting safety early on.
A new sandbox will explore how AI can spot side effects earlier.
🔗brnw.ch/21x3cIW
The May issue of Regulatory Rapporteur is now available.
From entry-level through to leadership, this issue offers a clear view of how careers in regulatory affairs are evolving and where they can take you.
Read here: regulatoryrapporteur.org/reg…#TOPRA#RegulatoryRapporteur
⏰ Next week!
We’re joining @ISoPonline Africa Chapter Meeting as Silver Sponsor in Windhoek 🇳🇦
Essential and timely discussions on advancing patient safety & strengthening PV collaboration across Africa 🌍
Connect with us at show 📧 🤝
#ISoPAfrica#pharmacovigilance
Excited to join @ISoPonline Africa Chapter Meeting as Silver Sponsor in Windhoek 🇳🇦
A vital space to advance patient safety & strengthen PV collaboration across Africa 🌍
Looking forward to meaningful conversations!
#ISoPAfrica#pharmacovigilance#drugsafety#MakingSafetyEasy
🗓️ Meet AB Cube at AcADM 2026 in Toulouse!
We’re showcasing how Marvin EDC SafetyEasy® unify clinical & safety data 🚀
🤝 Collaboration
🔄 EDC–PV automation
⚡ Faster signals
📊 One connected workflow
Meet our team on site 👥
🔗 meetings-toulouse.fr/agenda/…#AcADM2026
🚀 Opening day at #DIAEurope in Rotterdam!
Today also marks #ADEAwareness Day — a reminder that patient safety is at the heart of everything we do.💙
Proud to stand with our community advancing drug safety & smarter PV solutions.
🔗 fourthcause.org/#pharmacovigilance
Thanks to all who joined our first 2026 webinar as we kicked off AB Cube’s 20th anniversary! 🎉
We shared our roadmap, key regulatory updates, progress toward a near‑touchless case lifecycle, and unveiled CasEasy V3 Converter V2. 🚀
Want the highlights?
📧 sales@ab-cube.com
⏰ One week to go!
Join our live webinar as we unveil major new updates to the SafetyEasy® ecosystem — faster workflows, new capabilities and powerful enhancements for 2026. 🚀
📅 March 17, 2026 — 2:30 PM CET
🔗 Register: events.teams.microsoft.com/e…
Big news! 🚀
@ABCube1 becomes AB Cube Group — bringing Marvin, asthenis & SafetyEasy® together into one connected life sciences platform across oncology, clinical data and safety. 🏥 📊 🛡️
🔗 ab-cube.com/news-insights/ab…
📣 ICYMI: Our new whitepaper is live!
🇪🇺 Pharmacovigilance SaaS: Key Differences Between EU & US Providers 🇺🇸
Discover why GDPR‑centric EU platforms offer stronger compliance, data privacy & agility for global PV teams.
📥 Download: ab-cube.com/resources-downlo…#MakingSafetyEasy
📣 One week to go!
We’re heading to European Drug Safety & AI 2026 conference in Barcelona (24–25 Feb)
We’ll be sharing how SafetyEasy® Suite our AI‑driven automation modules help streamline drug safety operations. ⚙️📈
Want to meet us there?
👉 ab-cube.com/events-webinars/…
📣✨ UPCOMING: AB Cube will attend the European Drug Safety & AI 2026 conference
🗓️ 24–25 Feb
📍 Barcelona
We’ll be onsite to share insights & discuss how SafetyEasy® Suite our AI automation modules streamline drug safety ⚙️📈
Book a meeting: 🔗 ab-cube.com/events-webinars/…
🚀 Our 2026 roadmap is live — and we’re celebrating 20 years of shaping the future of #pharmacovigilance.
✨ From our first SaaS platform to today’s AI‑driven solutions, AB Cube has spent two decades innovating, building trust & driving compliance.
#20YearsOfABCube
🚀 AB Cube kicks off 2026!
We’re heading to:
🧠 Drug Safety & AI Summit, Barcelona – Feb 24–25
🌍 DIA Europe, Rotterdam – Mar 24–26
Sharing insights on how AI automation are transforming PV and next‑gen drug safety.
#MakingSafetyEasy#pharmacovigilance#AI
🎄✨ Season’s Greetings ✨🎄
As 2025 draws to a close, our sincere thanks to our customers & partners for your trust & collaboration throughout the year. 🤝
Wishing you a Merry Christmas and a prosperous New Year 🎁🌟
We look forward to achieving even more together in 2026! 🚀